Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

July
24
2018

Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018

BOCA RATON, Fla., July 24, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management…

July
20
2018

Is Your Blood Pressure Medicine Increasing Your Risk of Skin Cancer?

A recent study published in the Journal of American Dermatology has suggested a link between a commonly prescribed blood pressure medicine and skin cancer. Researchers at the University of Southern Denmark found that one of…

July
13
2018

Dr. Kevin Schewe on Colorado’s Best – Non-Surgical Technology for Skin Cancer – Alliance Cancer Care at Red Rocks

Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado’s Best on FOX network Channel…

July
12
2018

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community BOCA RATON, Fla., July 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy